61 results
424B3
CTCX
Carmell Therapeutics Corporation
29 Jul 24
Prospectus supplement
8:39am
Exhibit A
Majority Owner, BrainTrust Founders Studio
Limited Partner, BrainTrust Fund I
KBF Ventures: holding company for my private investments
8-K
EX-10.1
CTCX
Carmell Therapeutics Corporation
29 Jul 24
Carmell Corporation Appoints New Ceo
8:38am
Name: Kendra Bracken-Ferguson
Exhibit A
Majority Owner, BrainTrust Founders Studio
Limited Partner, BrainTrust Fund I
KBF Ventures: holding company
DEF 14A
CTCX
Carmell Therapeutics Corporation
14 Jun 24
Definitive proxy
8:24am
?
The presence, by virtual attendance or by proxy, of the holders of a majority of the shares entitled to vote at the Annual Meeting shall constitute … of our company.
Director Independence
The applicable rules of The Nasdaq Stock Market (“Nasdaq”) require that a majority of the Board be independent
424B3
CTCX
Carmell Therapeutics Corporation
5 Jun 24
Prospectus supplement
6:06am
rules of Nasdaq require a majority of a listed company’s board of directors to be comprised of independent directors within one year of listing … stockholder as any entity (other than the corporation and any direct or indirect majority-owned subsidiary of the corporation) or person beneficially owning
8-K
EX-10.2
nq14jhue fg
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
EX-10.1
jpc7dtwgm
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K/A
EX-99.3
qy0a1y 4tra2w41pjc64
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K/A
EX-99.3
3f7u82loxb
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K/A
EX-99.2
19ll7x9mxo 6f
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K
EX-3.1
yk4 ladbfj5m
14 Aug 23
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
7:01am